Publications by authors named "Dimitra Gika"

Claim this Profile
E
Early Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With Myeloma.
Efstathios Kastritis, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, Magdalini Migkou, Dimitra Gika

Clin Lymphoma Myeloma Leuk· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patients.
Maria Gavriatopoulou, Despina Fotiou, Ursula Koloventzou, Maria Roussou, Magdalini Migkou, Dimitra Gika

Leuk Lymphoma· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies.
Flora Zagouri, Efstathios Kastritis, Athanasios Zomas, Evangelos Terpos, Eirini Katodritou, Dimitra Gika

Eur J Haematol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BDR in newly diagnosed patients with WM: final analysis of a phase 2 study after a minimum follow-up of 6 years.
Maria Gavriatopoulou, Ramón García-Sanz, Efstathios Kastritis, Pierre Morel, Marie-Christine Kyrtsonis, Dimitra Gika

Blood· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis.
Meletios A Dimopoulos, Maria Roussou, Maria Gavriatopoulou, Erasmia Psimenou, Evangelos Eleutherakis-Papaiakovou, Dimitra Gika

Am J Hematol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study.
Efstathios Kastritis, Maria Gavriatopoulou, Marie-Christine Kyrtsonis, Maria Roussou, Evdoxia Hadjiharissi, Dimitra Gika

Blood· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary therapy of Waldenstrom macroglobulinemia (WM) with weekly bortezomib, low-dose dexamethasone, and rituximab (BDR): long-term results of a phase 2 study of the European Myeloma Network (EMN).
Meletios A Dimopoulos, Ramón García-Sanz, Maria Gavriatopoulou, Pierre Morel, Marie-Christine Kyrtsonis, Dimitra Gika

Blood· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients.
Lia A Moulopoulos, Meletios A Dimopoulos, Efstathios Kastritis, Dimitrios Christoulas, Maria Gkotzamanidou, Dimitra Gika

Am J Hematol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple myeloma in octogenarians: clinical features and outcome in the novel agent era.
Meletios A Dimopoulos, Efstathios Kastritis, Sossana Delimpasi, Eirini Katodritou, Eleftheria Hatzimichael, Dimitra Gika

Eur J Haematol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short progression-free survival predicts for poor overall survival in older patients with multiple myeloma treated upfront with novel agent-based therapy.
Magdalini Migkou, Efstathios Kastritis, Maria Roussou, Maria Gkotzamanidou, Maria Gavriatopoulou, Dimitra Gika

Eur J Haematol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased serum lactate dehydrongenase should be included among the variables that define very-high-risk multiple myeloma.
Maria Gkotzamanidou, Efstathios Kastritis, Maria Roussou Magdalini Migkou Maria Gavriatopoulou, Nikitas Nikitas, Dimitra Gika

Clin Lymphoma Myeloma Leuk· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years.
Efstathios Kastritis, Marie-Christine Kyrtsonis, Evdoxia Hatjiharissi, Argiris Symeonidis, Eurydiki Michalis, Dimitra Gika

Am J Hematol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostication of the high-risk WM patient.
Efstathios Kastritis, Maria Gavriatopoulou, Marie-Christine Kyrtsonis, Michael Michael, Evdoxia Hadjiharissi, Dimitra Gika

Clin Lymphoma Myeloma Leuk· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH).
Efstathios Kastritis, Marie-Christine Kyrtsonis, Evdoxia Hadjiharissi, Argyris Symeonidis, Evridiki Michalis, Dimitra Gika

Leuk Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents.
Maria Roussou, Efstathios Kastritis, Dimitrios Christoulas, Magdalini Migkou, Maria Gavriatopoulou, Dimitra Gika

Leuk Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prechemotherapy serum levels of CD105, transforming growth factor beta2, and vascular endothelial growth factor are associated with prognosis in patients with advanced epithelial ovarian cancer treated with cytoreductive surgery and platinum-based chemotherapy.
George Bozas, Evangelos Terpos, Dimitra Gika, Alexandra Karadimou, Meletios A Dimopoulos

Int J Gynecol Cancer· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostication in young and old patients with Waldenström's macroglobulinemia: importance of the International Prognostic Scoring System and of serum lactate dehydrogenase.
Efstathios Kastritis, Konstantinos Zervas, Panagiotis Repoussis, Evridiki Michali, Eirini Katodrytou, Dimitra Gika

Clin Lymphoma Myeloma· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary treatment of Waldenström macroglobulinemia with dexamethasone, rituximab, and cyclophosphamide.
Meletios Athanasios Dimopoulos, Athanasios Anagnostopoulos, Marie-Christine Kyrtsonis, Konstantinos Zervas, Constantinos Tsatalas, Dimitra Gika

J Clin Oncol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced epithelial ovarian cancer in the elderly: chemotherapy tolerance and outcome.
Eleni Efstathiou, Meletios A Dimopoulos, George Bozas, Efstathios Kastritis, Lia A Moulopoulos, Dimitra Gika

Anticancer Res· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents.
Efstathios Kastritis, Athanasios Anagnostopoulos, Maria Roussou, Dimitra Gika, Charis Matsouka

Haematologica· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinoma.
George Bozas, Aristotle Bamias, Vassiliki Koutsoukou, Eleni Efstathiou, Dimitra Gika

Gynecol Oncol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Young age is associated with favorable characteristics but is not an independent prognostic factor in patients with epithelial ovarian cancer: a single institution experience.
George Bozas, Meletios A Dimopoulos, Efstathios Kastritis, Eleni Efstathiou, Vassiliki Koutsoukou, Dimitra Gika

Oncology· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The outcome of patients with advanced pure squamous or mixed squamous and transitional urothelial carcinomas following platinum-based chemotherapy.
Efstathios Kastritis, Meletios-Athanasios Dimopoulos, Nikolaos Antoniou, Charalambos Deliveliotis, Michael Chrisofos, Dimitra Gika

Anticancer Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of serum beta2-microglobulin in patients with Waldenstrom's macroglobulinemia requiring treatment.
Athanasios Anagnostopoulos, Konstantinos Zervas, Marie Kyrtsonis, Argyris Symeonidis, Dimitra Gika

Clin Lymphoma Myeloma· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.
Aristotle Bamias, Christos Papadimitriou, Eleni Efstathiou, Alexandros Rodolakis, Georgios Vlahos, Dimitra Gika

BMC Cancer· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis